Position in ZYME
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,711,579
-$120,331 QoQ
Shares Held
148,226
+1.8% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $354,986,312 across 62 Biotechnology names. ZYME ranks #35 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
484,580 | $31,318,405 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
1,199,598 | $29,702,046 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
137,099 | $14,450,234 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
360,490 | $13,875,260 | |
| 5 | NAMS |
NewAmsterdam Pharma Co N.V.
|
408,492 | $13,075,828 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
304,615 | $12,279,030 | |
| 7 | CLDX |
Celldex Therapeutics, Inc.
|
352,302 | $11,175,019 | |
| 8 | APGE |
Apogee Therapeutics, Inc.
|
122,669 | $10,325,049 |
All Filings in ZYME
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,711,579 | 148,226 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,831,910 | 145,534 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,501,195 | 146,440 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,844,272 | 146,954 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,623,559 | 136,319 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,048,911 | 139,953 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,801,929 | 143,580 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,238,392 | 145,522 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,623,888 | 154,362 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,621,193 | 156,034 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,005,999 | 158,675 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $733,786 | 84,929 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $709,432 | 78,477 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $616,420 | 78,425 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $482,123 | 78,394 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||